查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1806346

生物样本库市场按类型、组件、样本类型、应用和最终用户划分－2025-2030 年全球预测

Biobanks Market by Type, Component, Sample Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年生物银行市场价值将达到1,154.3亿美元，2025年成长至1,305.6亿美元，复合年增长率为13.49%，到2030年将达到2,467.2亿美元。

主要市场统计数据
基准年2024年 1154.3亿美元
预计2025年 1305.6亿美元
预测年份 2030 2467.2亿美元
复合年增长率（%） 13.49%

揭示现代生物库在塑造生物医学研究和医疗保健创新未来的重要基础和策略重要性

现代生物样本库是支持转化研究、个人化医疗和治疗创新发展的基础支柱。透过系统地收集、处理、储存和分发高品质的生物检体，这些样本库弥合了发现科学与临床应用之间的差距。此外，强大的资料管理系统与实体检体库的整合，使生物样本库从单纯的储存设施提升为充满活力的研究推动者，促进了学术界、产业界和医疗机构之间的合作。

探索透过技术进步、数据整合和协作生态系统改变生物库营运的重大模式转移

由于技术突破和合作模式的转变，生物样本库的模式正在发生巨大变化。高通量基因组定序平台如今能够同时快速分析数千个样本，从而为疾病机制和患者分层提供新的见解。同时，人工智慧和机器学习演算法的引入正在彻底改变资料管理和模式识别，以前所未有的速度推动预测分析和生物标记发现。

评估美国2025年关税政策对生物库供应链的深远影响：创新成本与全球合作

美国2025年关税法案的实施为依赖复杂全球供应链的生物样本库营运带来了复杂的挑战。实验室耗材、低温储存系统和敏感设备的关税上调，推高了成本，并导致采购延误。因此，生物样本库管理人员正在审查供应商合同，探索替代筹资策略，并探索近岸外包机会，以减轻进口关税上涨的影响。

分析关键细分维度、各种生物库类型、元件、样本类型、应用程式和最终用户动态，揭示市场动态

由于生物样本库服务于多元化的研究、临床和商业终端用户，因此对市场区隔的细緻理解是製定精准策略的基础。以疾病为导向的模型专注于与特定病理相关的检体，为肿瘤学、心臟病学和神经病学研究提供客製化的资源。相反，基于基因组的样本库管理DNA和RNA萃取物，以支持群体基因组学和变异发现；而基于人群的样本库则收集不同人口群体的样本，以支持流行病学研究。虚拟生物样本库将元资料记录整合到可存取的数位图书馆中，有效地实现了无需实际出行即可发现样本的民主化。

了解美洲、欧洲、中东和非洲以及亚太地区的生物银行生态系统的区域动态和战略机会

由于地缘政治因素、资金筹措状况和监管环境因地区而异，区域动态显着影响生物样本库计画的战略轨迹。在美洲，强劲的公共和私人投资培育了一个成熟的生态系统，其特点是成熟的样本库与领先的学术医疗中心和创新的生物技术丛集相结合。监管监督确保了患者知情同意和资料隐私标准，而北美和南美的跨境合作则促进了大规模队列研究的进行。

确定产业领导者；策略联盟和竞争优势将塑造生物银行市场格局的未来发展轨迹

生物样本库领域的领先公司正透过策略合作伙伴关係、技术创新和不断扩展的服务组合来脱颖而出。领先的生命科学公司利用全球分销网络，提供整合样本管理软体、低温运输物流和可客製化分析工作流程的承包生物样本库解决方案；而专业服务供应商与学术医疗中心合作，共同开发以疾病为重点的样本库，以加速转化研究成果的转化。

生物样本库领导者的策略必要事项：因应复杂的监管环境；拥抱创新，加强全球伙伴关係，实现持续成长

为了在技术创新快速、监管复杂的时代取得成功，生物样本库领导者必须制定兼顾敏捷性和管治的策略蓝图。优先投资数位基础设施，可以即时追踪样本来源、实现自动化品管检查，并与外部资料来源无缝整合。同时，透过多供应商采购和区域伙伴关係实现供应链多元化，可以降低贸易政策和物流中断带来的风险。

严谨的研究框架，协助提供全面的生物样本库市场情报。了解更多关于我们的资料收集方法和分析方法。

这项全面分析背后的调查方法融合了多种资料收集和分析手段，以确保研究的深度和可靠性。主要见解是透过与领先生物样本库的高阶主管、科学总监和采购经理进行结构化访谈收集的。这些第一手观点提供了营运挑战、技术应用趋势和策略重点的背景资讯。

综合关键见解和策略要点，帮助决策者引导生物库倡议走向长期成功和影响

摘要，生物样本库已成为生物医学研究和医疗保健创新体系中具有策略意义的重要部分。基因组学、数据分析和数位整合领域的技术进步正在重塑营运模式，而关税政策和供应链考量也带来了新的复杂性，需要积极主动的管理。详细的细分洞察揭示了对疾病导向、基于基因组、人群和虚拟样本库的多样化需求，每种需求都由专门的组件和服务提供支援。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 个人化医疗需求的不断增长推动了全球生物银行设施的扩张
  • 整合人工智慧和巨量资料分析，改进生物样本库处理
  • 增加政府津贴和资助倡议，加强生物银行研究能力
  • 扩大大规模基于人群和针对特异性疾病的生物库，用于多样化的医学研究
  • 引进自动化储存和检索技术，提高生物库营运效率
  • 冷冻保存技术的进步提高了生物检体的长期品质和稳定性
  • 透过生物库和製药公司之间的策略伙伴关係和合作加速药物发现
  • 解决影响现代生物库管治架构的伦理挑战与资料隐私问题
  • 生物样本库在罕见和复杂疾病研究中的重要性日益增强，有助于提供更好的诊断解决方案
  • 商业生物样本库的出现，为全球研究提供了高品质的生物样本

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章：2025年美国关税的累积影响

第 8 章 生物样本库市场（按类型）

  • 以疾病为导向的生物库
  • 基于基因组的生物库
  • 基于人群的生物样本库
  • 虚拟生物库

第九章生物样本库市场（按组成部分）

  • 耗材
  • 装置
    • 培养箱和离心机
    • 监控系统
    • 温度控制系统
      • 低温储存系统
      • 冷冻库和冰箱
      • 解冻装置
  • 服务
    • 资料管理
    • 样品分析
    • 储存和处理
    • 运输

第 10 章。生物样本库市场（按样本类型）

  • 血液製品
  • 细胞株
  • 核酸
  • 组织

第 11 章 生物样本库市场（按应用）

  • 临床诊断
  • 个人化医疗
  • 调查
  • 治疗药物
    • 药物开发
    • 基因编辑

第 12 章 生物样本库市场（按最终用户划分）

  • 学术机构
  • 生技公司
  • 医院
  • 製药公司

第 13 章：美洲生物银行市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 欧洲、中东和非洲生物银行市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

15. 亚太生物库市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十六章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • ASKION GmbH
    • Avantor, Inc.
    • Bay Biosciences LLC
    • Beckman Coulter, Inc. by Danaher Corporation
    • Becton, Dickinson and Company
    • BioIVT LLC
    • BioKryo by L'AIR LIQUIDE SA
    • BioLife Solutions Inc.
    • BocaBio
    • Charles River Laboratories International, Inc.
    • Cryoport Systems, LLC
    • CTIBiotech
    • Cureline, Inc.
    • Firalis Group
    • Greiner AG
    • Hamilton Company
    • LVL Technologies GmbH & Co. KG
    • Merck KGaA
    • Micronic Holding BV
    • ProteoGenex, Inc.
    • Provia Laboratories, LLC
    • Qiagen NV
    • Shanghai Outdo Biotech Co. Ltd
    • Taylor-Wharton
    • Tecan Trading AG
    • Thermo Fisher Scientific Inc.
    • UK Biobank Limited

第十七章 研究人工智慧

第十八章 研究统计

第十九章 研究联络人

第二十章 研究报导

第21章 附录

Product Code: MRR-437D4595886E

The Biobanks Market was valued at USD 115.43 billion in 2024 and is projected to grow to USD 130.56 billion in 2025, with a CAGR of 13.49%, reaching USD 246.72 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 115.43 billion
Estimated Year [2025] USD 130.56 billion
Forecast Year [2030] USD 246.72 billion
CAGR (%) 13.49%

Unveiling the Pivotal Foundations and Strategic Importance of Modern Biobanks in Shaping the Future of Biomedical Research and Healthcare Innovations

Modern biobanks serve as foundational pillars underpinning the advancement of translational research, personalized medicine, and therapeutic innovation. By systematically collecting, processing, storing, and distributing high-quality biological specimens, these repositories bridge the gap between discovery science and clinical application. Moreover, the integration of robust data management systems with physical sample archives has elevated biobanks from mere storage facilities to dynamic research enablers, fostering collaborations across academia, industry, and healthcare institutions.

As demand for precision diagnostics and targeted therapies intensifies, biobanks have embraced rigorous quality control measures, standardized protocols, and ethical governance frameworks. This ensures that researchers access well-characterized, consented specimens, thereby accelerating biomarker identification and drug development processes. Additionally, strategic alignment with regulatory agencies and adherence to international best practices have reinforced trust among stakeholders, paving the way for large-scale, multi-center studies that can yield statistically significant findings.

Looking ahead, biobanks will continue to evolve through technological adoption and network expansion, further reducing barriers to entry for research teams worldwide. The ability to harmonize genomic, proteomic, and clinical data with diverse sample types positions biobanks at the forefront of biomedical innovation. This introduction lays the groundwork for exploring transformative shifts, policy impacts, and strategic imperatives that define the contemporary biobank landscape.

Exploring the Major Paradigm Shifts Revolutionizing Biobank Operations Through Technological Advancements Data Integration and Collaborative Ecosystems

The biobank landscape has undergone seismic transformations driven by technological breakthroughs and shifting collaboration models. High-throughput genomic sequencing platforms now enable rapid analysis of thousands of samples in parallel, unlocking novel insights into disease mechanisms and patient stratification. Concurrently, the implementation of artificial intelligence and machine learning algorithms has revolutionized data curation and pattern recognition, enhancing predictive analytics and biomarker discovery at unprecedented speeds.

Digital biobank platforms have emerged as critical hubs, seamlessly connecting disparate sample repositories and enabling remote access to specimen metadata and analytic tools. Blockchain-based solutions are also gaining traction, offering immutable audit trails that bolster data integrity and consent management. These advancements have fostered a culture of open science, driving consortia-based research initiatives that draw on heterogeneous sample collections across geographical and institutional boundaries.

Moreover, the rise of virtual biobanks has reduced reliance on physical specimen transfers, as in silico data sharing becomes more prevalent. Collaborative ecosystems now span public-private partnerships, clinical networks, and patient advocacy groups, each contributing to rich multi-omics datasets. These paradigm shifts are redefining biobank value propositions, positioning them as strategic assets capable of propelling next-generation therapies and population health studies.

Assessing the Far-Reaching Consequences of United States 2025 Tariff Policies on Biobank Supply Chains Innovation Costs and Global Collaborations

The implementation of United States tariff policies in 2025 has introduced complex challenges for biobank operations that rely on intricate global supply chains. Heightened duties on laboratory consumables, cryogenic storage systems, and precision equipment have spurred cost inflation and procurement delays. As a result, biobank managers are reassessing vendor contracts, seeking alternative sourcing strategies, and exploring near-shoring opportunities to mitigate exposure to escalating import levies.

Furthermore, tariff-driven price volatility has reverberated through service portfolios, affecting sample analysis, data management, and logistics. Contract laboratories and transport providers have had to adjust their pricing models, prompting end users to negotiate multi-year agreements that lock in favorable terms. In parallel, some biobanks have intensified efforts to localize manufacturing of critical supplies, forging joint ventures with domestic producers to ensure continuity of operations and foster supply chain resilience.

To navigate this evolving landscape, industry stakeholders are engaging with trade associations and government bodies to seek clarifications, exemptions, and renegotiation of tariff schedules. Enhanced transparency in procurement planning and collaborative risk-sharing arrangements have emerged as essential components of strategic mitigation frameworks. By proactively addressing these tariff impacts, biobanks can preserve cost structures, maintain service quality, and sustain momentum in research and development endeavors.

Analyzing Critical Segmentation Dimensions Illuminating Diverse Biobank Types Components Sample Types Applications and End User Dynamics Driving Market Nuances

A nuanced understanding of market segmentation underpins targeted strategy development, as biobanks cater to diverse research, clinical, and commercial end users. The disease-oriented model focuses on specimens linked to specific pathologies, providing tailored resources for oncology, cardiology, and neurology studies. Conversely, genomic-based repositories curate DNA and RNA extracts to support population genomics and variant discovery efforts, while population-based collections gather samples across demographic cohorts to enable epidemiological research. Virtual biobanks consolidate metadata records into accessible digital libraries, effectively democratizing sample discovery without physical transfers.

Components of the biobanking ecosystem encompass consumables, specialized equipment, and a broad spectrum of services. Consumables such as reagents and storage vials are indispensable for daily operations, whereas equipment investments span incubators, centrifuges, and monitoring systems. The critical temperature control infrastructure integrates cryogenic storage systems, freezers, refrigerators, and thawing equipment to preserve sample integrity. Services extend from data management platforms and high-throughput sample analysis to storage, processing workflows and secure transport solutions tailored to sensitive biomaterials.

Sample types range from blood derivatives and cell lines to nucleic acids and tissue specimens, each demanding bespoke handling protocols. Applications traverse clinical diagnostics, personalized medicine initiatives, foundational research projects, and therapeutics development, including drug discovery pipelines and cutting-edge gene editing programs. End users such as academic institutions, biotechnology ventures, healthcare providers and pharmaceutical companies leverage biobanks to accelerate innovation. By dissecting these segmentation layers, stakeholders can craft offerings that align precisely with evolving research imperatives and commercial objectives.

Understanding the Distinct Regional Dynamics and Strategic Opportunities Across Americas Europe Middle East Africa and Asia Pacific Biobank Ecosystems

Regional dynamics profoundly influence the strategic trajectory of biobank initiatives, as geopolitical factors, funding landscapes and regulatory frameworks vary across territories. In the Americas, robust investment from public and private sectors has cultivated a mature ecosystem, characterized by well-established repositories integrated with leading academic medical centers and innovative biotech clusters. Regulatory oversight ensures patient consent and data privacy standards, while cross-border collaborations within North and South America facilitate large cohort studies.

In Europe, the Middle East, and Africa, harmonization of regulatory requirements under pan-European directives has enabled seamless sample exchanges and joint research consortia. Public funding programs and philanthropic foundations continue to underwrite comprehensive biobank networks, spanning national initiatives and disease-specific platforms. Emerging centers in North Africa and the Gulf region are also driving capacity building, often in partnership with established European counterparts.

The Asia-Pacific region is witnessing exponential growth, fueled by government-led precision medicine agendas and substantial investments in biotech infrastructure. Nations with large population bases are prioritizing biobank development to support public health surveillance, translational research and commercial R&D ventures. Strategic alliances between local research institutes and international technology providers are laying the groundwork for sustainable biobanking operations that can serve both domestic and global scientific communities.

Identifying Leading Industry Players Strategic Collaborations and Competitive Differentiators Shaping the Future Trajectory of the Biobank Market Landscape

Leading players in the biobank sector are differentiating through strategic partnerships, technological innovation and expanded service portfolios. Premier life sciences companies are leveraging their global distribution networks to offer turnkey biobanking solutions that integrate sample management software, cold chain logistics and customizable analytic workflows. Meanwhile, specialized service providers are forging alliances with academic medical centers to co-develop disease-focused repositories and accelerate translational research outputs.

Collaborations between equipment manufacturers and software developers have yielded integrated platforms that streamline operations from sample accessioning to data visualization. This convergence of hardware and digital solutions is enabling end users to optimize throughput, reduce manual error, and comply with stringent quality guidelines. Additionally, select market entrants are pursuing vertical integration, establishing in-house sequencing and bioinformatics capabilities that complement traditional storage and processing services.

Competitive differentiation is increasingly driven by value-added offerings such as advanced multi-omics profiling, secure remote access portals, and robust regulatory support. Companies that demonstrate proficiency in navigating complex compliance environments, while delivering scalable solutions, are gaining traction among pharmaceutical sponsors and research consortia. By continuously refining their ecosystems of services and technology, these leaders are setting new benchmarks for operational excellence and customer engagement.

Crafting Strategic Imperatives for Biobank Leaders to Navigate Regulatory Complexities Embrace Innovation and Strengthen Global Partnerships for Sustainable Growth

To thrive in an era of rapid innovation and regulatory complexity, biobank leaders must develop strategic roadmaps that balance agility with governance. Prioritizing investments in digital infrastructure will enable real-time tracking of sample provenance, automated quality control checks, and seamless integration with external data sources. Concurrently, diversifying supply chains through multi-vendor sourcing and regional partnerships can mitigate risks associated with trade policies and logistical disruptions.

Cultivating collaborative alliances with research institutions, patient advocacy groups and technology providers is essential for expanding specimen diversity and fostering translational breakthroughs. By co-investing in shared platforms and standardizing protocols, stakeholders can unlock economies of scale and accelerate study timelines. Equally important is the establishment of robust governance frameworks that address consent management, ethical use, and data privacy, thereby reinforcing stakeholder trust.

Finally, enhancing workforce capabilities through continuous training in bioinformatics, regulatory affairs and quality management will ensure that biobank teams remain at the cutting edge of best practices. Leaders should also explore public-private partnerships to leverage grant funding, tax incentives, and infrastructure support. By implementing these actionable measures, organizations can solidify their competitive positioning and drive long-term value for researchers and end users alike.

Detailing Rigorous Research Frameworks Data Collection Techniques and Analytical Approaches Underpinning Comprehensive Biobank Market Intelligence

The research methodology underpinning this comprehensive analysis combined multiple data collection techniques and analytical approaches to ensure depth and reliability. Primary insights were garnered through structured interviews with senior executives, scientific directors and procurement managers across leading biobank operations. These firsthand perspectives provided context on operational challenges, technology adoption trends and strategic priorities.

Secondary research encompassed a systematic review of scientific literature, patent filings, regulatory guidelines, and industry white papers. This review was augmented by data extraction from reputable public sources, enabling cross-validation of key developments in supply chains, tariff impacts, and collaborative frameworks. In addition, proprietary databases were consulted to map the competitive landscape and identify emerging service providers.

Data triangulation and thematic coding were applied to synthesize qualitative inputs with quantitative observations, producing cohesive insights that reflect market realities. A multi-stage validation process involved expert panel reviews and iterative feedback loops, ensuring that findings accurately represent the current biobank ecosystem. This rigorous methodology underlies the strategic analyses presented in this executive summary.

Synthesizing Key Insights and Strategic Takeaways to Empower Decision Makers in Steering Biobank Initiatives Toward Long Term Success and Impact

In summary, biobanks have ascended to a position of strategic importance within the biomedical research and healthcare innovation continuum. Technological advances in genomics, data analytics, and digital integration are reshaping operational paradigms, while tariff policies and supply chain considerations introduce new layers of complexity that demand proactive management. Nuanced segmentation insights reveal the diverse demands of disease-oriented, genomic-based, population and virtual repositories, each supported by specialized components and service offerings.

Regional dynamics underscore the need for tailored strategies that account for distinct regulatory frameworks, funding mechanisms, and collaborative ecosystems across the Americas, EMEA and Asia-Pacific. Leading companies are differentiating through holistic solution sets, strategic alliances and value-added services that encompass multi-omics profiling and advanced bioinformatics. To capitalize on these trends, biobank leaders must embrace digital transformation, diversify supply chains, and reinforce governance to maintain trust and compliance.

By synthesizing these insights, decision makers can chart a course toward sustainable growth, operational excellence and accelerated discovery. This executive summary provides the strategic foundation needed to navigate a rapidly evolving biobank landscape with confidence and clarity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Growing demand for personalized medicine fueling expansion of biobank facilities worldwide
  • 5.2. Integration of artificial intelligence and big data analytics in improving biobank sample processing
  • 5.3. Increasing government grants and funding initiatives boosting biobanking research capabilities
  • 5.4. Expansion of large-scale population-based and disease-specific biobanks for diverse medical studies
  • 5.5. Adoption of automated storage and retrieval technologies enhancing biobank operational efficiency
  • 5.6. Advancements in cryopreservation techniques improving long-term biospecimen quality and stability
  • 5.7. Strategic partnerships and collaborations between biobanks and pharmaceutical companies accelerating drug discovery
  • 5.8. Addressing ethical challenges and data privacy concerns shaping modern biobank governance frameworks
  • 5.9. Growing importance of biobanks in rare and complex disease research for better diagnostic solutions
  • 5.10. Emergence of commercial biobanks providing global access to high-quality biological samples for research

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Biobanks Market, by Type

  • 8.1. Introduction
  • 8.2. Disease-Oriented Biobanks
  • 8.3. Genomic-Based Biobanks
  • 8.4. Population-Based Biobanks
  • 8.5. Virtual Biobanks

9. Biobanks Market, by Component

  • 9.1. Introduction
  • 9.2. Consumables
  • 9.3. Equipment
    • 9.3.1. Incubators & Centrifuges
    • 9.3.2. Monitoring Systems
    • 9.3.3. Temperature Control Systems
      • 9.3.3.1. Cryogenic Storage Systems
      • 9.3.3.2. Freezers & Refrigerators
      • 9.3.3.3. Thawing Equipment
  • 9.4. Services
    • 9.4.1. Data Management
    • 9.4.2. Sample Analysis
    • 9.4.3. Storage & Processing
    • 9.4.4. Transport

10. Biobanks Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Blood Derivatives
  • 10.3. Cell Lines
  • 10.4. Nucleic Acid
  • 10.5. Tissues

11. Biobanks Market, by Application

  • 11.1. Introduction
  • 11.2. Clinical Diagnostics
  • 11.3. Personalized Medicine
  • 11.4. Research
  • 11.5. Therapeutics
    • 11.5.1. Drug Development
    • 11.5.2. Gene Editing

12. Biobanks Market, by End User

  • 12.1. Introduction
  • 12.2. Academic Institutions
  • 12.3. Biotechnology Companies
  • 12.4. Hospitals
  • 12.5. Pharmaceutical Companies

13. Americas Biobanks Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Biobanks Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Biobanks Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. ASKION GmbH
    • 16.3.2. Avantor, Inc.
    • 16.3.3. Bay Biosciences LLC
    • 16.3.4. Beckman Coulter, Inc. by Danaher Corporation
    • 16.3.5. Becton, Dickinson and Company
    • 16.3.6. BioIVT LLC
    • 16.3.7. BioKryo by L'AIR LIQUIDE S.A.
    • 16.3.8. BioLife Solutions Inc.
    • 16.3.9. BocaBio
    • 16.3.10. Charles River Laboratories International, Inc.
    • 16.3.11. Cryoport Systems, LLC
    • 16.3.12. CTIBiotech
    • 16.3.13. Cureline, Inc.
    • 16.3.14. Firalis Group
    • 16.3.15. Greiner AG
    • 16.3.16. Hamilton Company
    • 16.3.17. LVL Technologies GmbH & Co. KG
    • 16.3.18. Merck KGaA
    • 16.3.19. Micronic Holding B.V.
    • 16.3.20. ProteoGenex, Inc.
    • 16.3.21. Provia Laboratories, LLC
    • 16.3.22. Qiagen N.V.
    • 16.3.23. Shanghai Outdo Biotech Co. Ltd
    • 16.3.24. Taylor-Wharton
    • 16.3.25. Tecan Trading AG
    • 16.3.26. Thermo Fisher Scientific Inc.
    • 16.3.27. UK Biobank Limited

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. BIOBANKS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL BIOBANKS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. BIOBANKS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. BIOBANKS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. BIOBANKS MARKET: RESEARCHAI
  • FIGURE 26. BIOBANKS MARKET: RESEARCHSTATISTICS
  • FIGURE 27. BIOBANKS MARKET: RESEARCHCONTACTS
  • FIGURE 28. BIOBANKS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. BIOBANKS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOBANKS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOBANKS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOBANKS MARKET SIZE, BY DISEASE-ORIENTED BIOBANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOBANKS MARKET SIZE, BY DISEASE-ORIENTED BIOBANKS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOBANKS MARKET SIZE, BY GENOMIC-BASED BIOBANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOBANKS MARKET SIZE, BY GENOMIC-BASED BIOBANKS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOBANKS MARKET SIZE, BY POPULATION-BASED BIOBANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOBANKS MARKET SIZE, BY POPULATION-BASED BIOBANKS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOBANKS MARKET SIZE, BY VIRTUAL BIOBANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOBANKS MARKET SIZE, BY VIRTUAL BIOBANKS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOBANKS MARKET SIZE, BY INCUBATORS & CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOBANKS MARKET SIZE, BY INCUBATORS & CENTRIFUGES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOBANKS MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOBANKS MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOBANKS MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOBANKS MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOBANKS MARKET SIZE, BY FREEZERS & REFRIGERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOBANKS MARKET SIZE, BY FREEZERS & REFRIGERATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOBANKS MARKET SIZE, BY THAWING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOBANKS MARKET SIZE, BY THAWING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOBANKS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOBANKS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOBANKS MARKET SIZE, BY STORAGE & PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOBANKS MARKET SIZE, BY STORAGE & PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOBANKS MARKET SIZE, BY TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOBANKS MARKET SIZE, BY TRANSPORT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD DERIVATIVES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACID, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL BIOBANKS MARKET SIZE, BY TISSUES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOBANKS MARKET SIZE, BY TISSUES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL BIOBANKS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOBANKS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL BIOBANKS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOBANKS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL BIOBANKS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOBANKS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL BIOBANKS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOBANKS MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL BIOBANKS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOBANKS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL BIOBANKS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOBANKS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL BIOBANKS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOBANKS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL BIOBANKS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOBANKS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS BIOBANKS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES BIOBANKS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 129. CANADA BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. CANADA BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 133. CANADA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 134. CANADA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 137. CANADA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 138. CANADA BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. CANADA BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 147. MEXICO BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. MEXICO BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 149. MEXICO BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 150. MEXICO BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 151. MEXICO BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 152. MEXICO BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 153. MEXICO BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 154. MEXICO BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 155. MEXICO BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 156. MEXICO BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 157. MEXICO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. MEXICO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 159. MEXICO BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. MEXICO BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 165. BRAZIL BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. BRAZIL BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. BRAZIL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 168. BRAZIL BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 169. BRAZIL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 170. BRAZIL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 171. BRAZIL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 172. BRAZIL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 173. BRAZIL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 174. BRAZIL BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 175. BRAZIL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. BRAZIL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 177. BRAZIL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. BRAZIL BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 179. BRAZIL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 180. BRAZIL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 183. ARGENTINA BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. ARGENTINA BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. ARGENTINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 186. ARGENTINA BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 187. ARGENTINA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 188. ARGENTINA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 189. ARGENTINA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 190. ARGENTINA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 191. ARGENTINA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 192. ARGENTINA BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 193. ARGENTINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. ARGENTINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. ARGENTINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. ARGENTINA BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 197. ARGENTINA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 198. ARGENTINA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 199. ARGENTINA BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. ARGENTINA BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 221. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED KINGDOM BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED KINGDOM BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED KINGDOM BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED KINGDOM BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED KINGDOM BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 239. GERMANY BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. GERMANY BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 241. GERMANY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 242. GERMANY BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 243. GERMANY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 244. GERMANY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 245. GERMANY BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 246. GERMANY BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 247. GERMANY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 248. GERMANY BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 249. GERMANY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. GERMANY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. GERMANY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. GERMANY BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 253. GERMANY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 254. GERMANY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 255. GERMANY BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. GERMANY BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 257. FRANCE BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. FRANCE BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 259. FRANCE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 260. FRANCE BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 261. FRANCE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 262. FRANCE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 263. FRANCE BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 264. FRANCE BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 265. FRANCE BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 266. FRANCE BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 267. FRANCE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. FRANCE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 269. FRANCE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. FRANCE BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 271. FRANCE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 272. FRANCE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 273. FRANCE BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. FRANCE BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 275. RUSSIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. RUSSIA BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 277. RUSSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 278. RUSSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 279. RUSSIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 280. RUSSIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 281. RUSSIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 282. RUSSIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 283. RUSSIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 284. RUSSIA BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 285. RUSSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. RUSSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 287. RUSSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 289. RUSSIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 290. RUSSIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 291. RUSSIA BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. RUSSIA BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 293. ITALY BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. ITALY BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 295. ITALY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 297. ITALY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 298. ITALY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 299. ITALY BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 300. ITALY BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 301. ITALY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 302. ITALY BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 303. ITALY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. ITALY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 305. ITALY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. ITALY BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 307. ITALY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 308. ITALY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 309. ITALY BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. ITALY BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 311. SPAIN BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. SPAIN BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 313. SPAIN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 314. SPAIN BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 315. SPAIN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 316. SPAIN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 317. SPAIN BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 318. SPAIN BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 319. SPAIN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 320. SPAIN BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 321. SPAIN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. SPAIN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 323. SPAIN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. SPAIN BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 325. SPAIN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 326. SPAIN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 327. SPAIN BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. SPAIN BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 329. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 331. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 333. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 335. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 337. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 338. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 339. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 341. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 343. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 344. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 345. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 346. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 347. SAUDI ARABIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 348. SAUDI ARABIA BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 350. SAUDI ARABIA BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 351. SAUDI ARABIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 352. SAUDI ARABIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 353. SAUDI ARABIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 354. SAUDI ARABIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 355. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 356. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 357. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 358. SAUDI ARABIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 359. SAUDI ARABIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 360. SAUDI ARABIA BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 361. SAUDI ARABIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 362. SAUDI ARABIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 363. SAUDI ARABIA BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 364. SAUDI ARABIA BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 365. SOUTH AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 366. SOUTH AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 367. SOUTH AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 368. SOUTH AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 369. SOUTH AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 370. SOUTH AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 371. SOUTH AFRICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 372. SOUTH AFRICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2025-2030 (USD MILLION)
  • TABLE 373. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 374. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 375. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 376. SOUTH AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 377. SOUTH AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 378. SOUTH AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 379. SOUTH AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 380. SOUTH AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 381. SOUTH AFRICA BIOBANKS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 382. SOUTH AFRICA BIOBANKS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 383. DENMARK BIOBANKS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 384. DENMARK BIOBANKS MARKET SIZE, BY TYPE, 2025-20